Vertex Pharmaceuticals Correlations

VRTX Stock

USD 440.87 7.53 1.68%

The current 90-days correlation between Vertex Pharmaceuticals and Regeneron Pharmaceuticals is 0.49 (i.e., Very weak diversification). The correlation of Vertex Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Vertex Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Vertex Pharmaceuticals and DJI is 0.45 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Vertex Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

Moving together with Vertex Stock

0.69	EQ	Equillium	Pair Corr
0.68	VALN	Valneva SE ADR	Pair Corr
0.73	VCYT	Veracyte	Pair Corr
0.62	DRRX	Durect	Pair Corr
0.81	CDIOW	Cardio Diagnostics	Pair Corr
0.82	DVAX	Dynavax Technologies	Pair Corr
0.84	DYAI	Dyadic International	Pair Corr

Moving against Vertex Stock

0.74	DRTS	Alpha Tau Medical	Pair Corr
0.58	VIGL	Vigil Neuroscience	Pair Corr
0.54	KG	KING PHARMACEUTICALS INC Symbol Change	Pair Corr
0.34	VANI	Vivani Medical Buyout Trend	Pair Corr
0.75	ELAN	Elanco Animal Health	Pair Corr
0.49	VRNA	Verona Pharma PLC	Pair Corr
0.45	VTYX	Ventyx Biosciences	Pair Corr
0.42	EDIT	Editas Medicine	Pair Corr
0.39	VRCA	Verrica Pharmaceuticals	Pair Corr

Related Correlations Analysis

	BMRN	SRPT	SGEN	ALNY	NTLA	EDIT	BEAM	DNA	BNTX	MRNA
BMRN		0.85	0.0	-0.28	0.1	-0.5	0.83	-0.45	-0.28	0.79	BMRN
SRPT	0.85		0.0	-0.56	-0.11	-0.62	0.73	-0.49	-0.17	0.69	SRPT
SGEN	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	SGEN
ALNY	-0.28	-0.56	0.0		0.45	0.76	-0.05	0.34	0.39	0.08	ALNY
NTLA	0.1	-0.11	0.0	0.45		0.53	0.46	0.43	0.32	0.36	NTLA
EDIT	-0.5	-0.62	0.0	0.76	0.53		-0.11	0.68	0.7	-0.08	EDIT
BEAM	0.83	0.73	0.0	-0.05	0.46	-0.11		-0.07	0.12	0.87	BEAM
DNA	-0.45	-0.49	0.0	0.34	0.43	0.68	-0.07		0.5	-0.13	DNA
BNTX	-0.28	-0.17	0.0	0.39	0.32	0.7	0.12	0.5		0.1	BNTX
MRNA	0.79	0.69	0.0	0.08	0.36	-0.08	0.87	-0.13	0.1		MRNA
	BMRN	SRPT	SGEN	ALNY	NTLA	EDIT	BEAM	DNA	BNTX	MRNA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MRNA	+ 0.87	BEAM
SRPT	+ 0.85	BMRN
BEAM	+ 0.83	BMRN
MRNA	+ 0.79	BMRN
EDIT	+ 0.76	ALNY
BEAM	+ 0.73	SRPT

High negative correlations

EDIT	- 0.62	SRPT
ALNY	- 0.56	SRPT
EDIT	- 0.5	BMRN
DNA	- 0.49	SRPT
DNA	- 0.45	BMRN
BNTX	- 0.28	BMRN

Risk-Adjusted Indicators

There is a big difference between Vertex Stock performing well and Vertex Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vertex Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BMRN	1.59	(0.41)	0.00	(0.34)	0.00	0.00	4.26	(3.90)	12.59
SRPT	4.43	(1.63)	0.00	(1.16)	0.00	0.00	7.39	(9.60)	55.00
SGEN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALNY	2.38	0.38	0.11	0.35	3.03	(2.40)	5.92	(5.28)	21.83
NTLA	4.76	0.15	0.02	0.14	6.59	(4.82)	9.54	(7.79)	36.46
EDIT	5.18	0.93	0.17	0.43	4.99	(6.33)	13.33	(8.04)	30.98
BEAM	3.64	(0.37)	0.00	(0.19)	0.00	0.00	7.29	(10.63)	31.91
DNA	4.73	0.37	0.08	0.25	4.71	(5.62)	14.73	(7.43)	25.69
BNTX	2.80	0.16	0.05	0.19	3.31	(3.75)	6.03	(4.30)	25.06
MRNA	3.19	(0.37)	0.00	(0.24)	0.00	0.00	6.06	(7.82)	20.49

Vertex Pharmaceuticals Corporate Management

Jonathan JD	Executive Officer	Profile
Stephanie Franklin	Senior Officer	Profile
Mike Tirozzi	SVP Officer	Profile
Damian Esq	Chief VP	Profile
Ourania Tatsis	Executive Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC